Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-Interventional Study In Patients With Advanced And/Or Metastatic Renal Cell Carcinoma (mRCC) Treated With Sutent

NCT00873210 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00873210
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00873210 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-Interventional Study In Patients With Advanced And/Or Metastatic Renal Cell Carcinoma (mRCC) Treated With Sutent
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
May 31, 2009
Completion date
November 30, 2011
Enrollment
121 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

advanced or metastatic renal cell carcinoma, renal cancer